Polish Infermedica raises $10.25M in Series A funding

With the participation of existing investors – Karma Ventures, Inovo Venture Partners and DreamIT Ventures, as well as two new co-lead investors, EBRD and heal capital, Infermedica raised $10.25M Series A.

Infermedica is a team of over 100 people – medical doctors, software engineers, and data scientists – who are passionate about the potential of artificial intelligence in preliminary medical diagnosis.

Their solutions have been used over 6 million times in 17 language versions.

This additional funding will enable Infermedica to continue developing the technology and expand commercial operations, especially in the US and Germany.

- Advertisment -


Borussia Dortmund had over EUR 400 million revenues in financial year 2022/2023

In financial year 2022/2023, the lifting of COVID-19 pandemic related restrictions affecting Borussia Dortmund's business model led to an...